Atlas Molecular Pharma closes a €3 million funding round led by Inveready to advance its clinical program in rare diseases

by Inveready Asset Management

The round was led by Inveready, with participation from CDTI, Grupo SPRI, Kereon Partners, Endometrial DIDI, and CRB Inverbio. This funding will enable the company to carry out a Phase I–II clinical...

Read more

CIC bioGUNE, CRB Inverbío, Kereon Partners and private investors create Atlas Molecular Pharma to discover new drugs for the treatment of Rare and Ultra-Rare diseases

by CRB Health Tech

The new company, Atlas Molecular Pharma, will further develop its proprietary technology to act as a “drug discovery engine” for the discovery and development of drugs called pharmacological chape...

Read more

Transplant Biomedicals capta 1,5 millones de euros

by Caixa Capital Risc

Transplant Biomedicals ha cerrado una ronda de financiación de 1,5 millones de euros, liderada por Kereon Partners y en la que también ha participado Caixa Capital Risc, otros inversores privados y ...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Xcalibur Smart Mapping strengthens its g...

by MCH Private Equity

​Xcalibur Smart Mapping, recognised as the global leader in airborne...

Photos Stream